Vestal Point Capital, LP Tyra Biosciences, Inc. Transaction History
Vestal Point Capital, LP
- $1.9 Trillion
- Q2 2025
A detailed history of Vestal Point Capital, LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 2,655,000 shares of TYRA stock, worth $28.1 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
2,655,000
Previous 2,879,829
7.81%
Holding current value
$28.1 Million
Previous $26.8 Billion
5.13%
% of portfolio
1.34%
Previous 1.91%
Shares
3 transactions
Others Institutions Holding TYRA
# of Institutions
120Shares Held
59.8MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$129 Million2.55% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$43.3 Million93.82% of portfolio
-
Nextech Invest Ag4.06MShares$43 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$43 Million7.35% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$41.8 Million1.48% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $445M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...